[Effect of tetrahydroberberine on blockade of pre- and postsynaptic dopamine receptors (author's transl)].
D015107:4-Butyrolactone / Q000494:pharmacology; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001599:Berberine / Q000031:analogs & derivatives / Q000494:pharmacology*; D001600:Berberine Alkaloids / Q000494:pharmacology*; D003342:Corpus Striatum / Q000032:analysis; D006993:Hypnotics and Sedatives / Q000494:pharmacology*; D007980:Levodopa / Q000032:analysis; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects*
D001600:Berberine Alkaloids; D006993:Hypnotics and Sedatives; D011954:Receptors, Dopamine; D001599:Berberine; D007980:Levodopa; D001058:Apomorphine; D015107:4-Butyrolactone; C004645:canadine